Revenue Breakdown
Composition ()
No data
Revenue Streams
Vivos Therapeutics Inc (VVOS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Appliance sales to integrated providers, accounting for 26.9% of total sales, equivalent to $1.03M. Other significant revenue streams include Center revenue and Sleep testing services. Understanding this composition is critical for investors evaluating how VVOS navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Vivos Therapeutics Inc maintains a gross margin of 52.38%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -69.79%, while the net margin is -79.61%. These profitability ratios, combined with a Return on Equity (ROE) of -335.45%, provide a clear picture of how effectively VVOS converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, VVOS competes directly with industry leaders such as RBOT and ALUR. With a market capitalization of $14.76M, it holds a leading position in the sector. When comparing efficiency, VVOS's gross margin of 52.38% stands against RBOT's N/A and ALUR's 49.06%. Such benchmarking helps identify whether Vivos Therapeutics Inc is trading at a premium or discount relative to its financial performance.
